Literature DB >> 31469385

The effects of HIV/AIDS on the clinical profile and outcomes post pericardiectomy of patients with constrictive pericarditis: a retrospective review.

D P Naidoo1, G Laurence2, B Sartorius3, S Ponnusamy2.   

Abstract

OBJECTIVE: The clinical profile and surgical outcomes of patients with constrictive pericarditis were compared in HIV-positive and -negative individuals.
METHODS: This study was a retrospective analysis of patients diagnosed with constrictive pericarditis at Inkosi Albert Luthuli Central Hospital, Durban, over a 10-year period (2004-2014).
RESULTS: Of 83 patients with constrictive pericarditis, 32 (38.1%) were HIV positive. Except for pericardial calcification, which was more common in HIV-negative subjects (n = 15, 29.4% vs n = 2, 6.3%; p = 0.011), the clinical profile was similar in the two groups. Fourteen patients died preoperatively (16.9%) and three died peri-operatively (5.8%). On multivariable analysis, age (OR 1.17; 95% CI: 1.03-1.34; p = 0.02), serum albumin level (OR 0.63; 95% CI: 0.43-0.92; p = 0.016), gamma glutamyl transferase level (OR 0.97; 95% CI: 0.94-0.1.0; p = 0.034) and pulmonary artery pressure (OR 1.49; 95% CI: 1.07-2.08; p = 0.018) emerged as independent predictors of pre-operative mortality rate. Peri-operative complications occurred more frequently in HIV-positive patients [9 (45%) vs 6 (17.6%); p = 0.030].
CONCLUSIONS: Without surgery, tuberculous constrictive pericarditis was associated with a high mortality rate. Although peri-operative complications occurred more frequently, surgery was not associated with increased mortality rates in HIV-positive subjects.

Entities:  

Keywords:  ; HIV; constrictive pericarditis; pericardiectomy

Mesh:

Substances:

Year:  2019        PMID: 31469385      PMCID: PMC8802346          DOI: 10.5830/CVJA-2019-015

Source DB:  PubMed          Journal:  Cardiovasc J Afr        ISSN: 1015-9657            Impact factor:   1.167


  31 in total

1.  [Pericarditis in HIV infected patients: retrospective study of 40 cases in Ouagadougou, Burkina Faso].

Authors:  A Niakara; Y Kambire; Y J Drabo
Journal:  Sante       Date:  2001 Jul-Sep

2.  The role of histopathology in establishing the diagnosis of tuberculous pericardial effusions in the presence of HIV.

Authors:  H Reuter; L J Burgess; J Schneider; W Van Vuuren; A F Doubell
Journal:  Histopathology       Date:  2006-02       Impact factor: 5.087

Review 3.  Chronic constrictive tuberculous pericarditis: risk factors and outcome of pericardiectomy.

Authors:  B Cinar; Y Enç; O Göksel; S Cimen; B Ketenci; O Teskin; H Kutlu; E Eren
Journal:  Int J Tuberc Lung Dis       Date:  2006-06       Impact factor: 2.373

4.  Tuberculous pericarditis in Transkei.

Authors:  J I Strang
Journal:  Clin Cardiol       Date:  1984-12       Impact factor: 2.882

Review 5.  Tuberculous pericarditis.

Authors:  Bongani M Mayosi; Lesley J Burgess; Anton F Doubell
Journal:  Circulation       Date:  2005-12-06       Impact factor: 29.690

6.  Prognostic predictors in pericardiectomy for chronic constrictive pericarditis.

Authors:  Se Hun Kang; Jong-Min Song; Minsoo Kim; Suk Jung Choo; Cheol Hyun Chung; Duk-Hyun Kang; Jae-Kwan Song
Journal:  J Thorac Cardiovasc Surg       Date:  2013-02-04       Impact factor: 5.209

7.  Predictors of constrictive pericarditis after tuberculous pericarditis.

Authors:  P K Suwan; S Potjalongsilp
Journal:  Br Heart J       Date:  1995-02

Review 8.  Recent advances in HIV-associated cardiovascular diseases in Africa.

Authors:  Faisal F Syed; Mahmoud Umar Sani
Journal:  Heart       Date:  2013-05-16       Impact factor: 5.994

9.  Constrictive pericarditis requiring pericardiectomy at Groote Schuur Hospital, Cape Town, South Africa: causes and perioperative outcomes in the HIV era (1990-2012).

Authors:  Arthur K Mutyaba; Sarvesh Balkaran; Robert Cloete; Naude du Plessis; Motasim Badri; Johan Brink; Bongani M Mayosi
Journal:  J Thorac Cardiovasc Surg       Date:  2014-08-04       Impact factor: 5.209

Review 10.  Constrictive pericarditis--a curable diastolic heart failure.

Authors:  Faisal F Syed; Hartzell V Schaff; Jae K Oh
Journal:  Nat Rev Cardiol       Date:  2014-07-29       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.